Merck
Merck’s osteoporosis candidate shows some promise in trials
September 16, 2009Research and Development, Sales and Marketing Cancer, Merck
Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …
Merck launches Saflutan in first European markets
September 4, 2009Research and Development, Sales and Marketing Merck, ophthalmology
Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …
Merck unveils post-merger leadership team
September 3, 2009Research and Development, Sales and Marketing MA, Merck
The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …
Merck and Schering-Plough propose shareholder settlement
July 28, 2009Sales and Marketing MA, Merck
Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
Merck makes progress on vaccines supply issues
July 24, 2009Manufacturing and Production Merck
Merck & Co's new manufacturing facility in Durham, North Carolina, is on schedule to start production of vaccines in the …
Merck signs anticoagulant collaboration
July 17, 2009Research and Development, Sales and Marketing Merck, cv
Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
Merck takes aim at neglected tropical diseases
June 25, 2009Research and Development, Sales and Marketing Africa, Merck, Orphan
Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …
AstraZeneca and Merck launch early stage trial collaboration
June 3, 2009Research and Development AZ, AstraZeneca, Cancer, Merck
Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …
Merck acquires rights to atrial fibrillation candidate
April 16, 2009Research and Development, Sales and Marketing Merck, cv
Merck has signed an agreement with Vancouver-based Cardiome Pharma to develop its new treatment for atrial fibrillation vernakalant.Merck will pay …
2-in-1: Merck and Schering-Plough
April 8, 2009Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma
The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …
Merck’s mega-merger will mark a return to sales growth
March 16, 2009Sales and Marketing MA, Merck
As a standalone company, Merck & Co. faces a tough future of declining sales. Analysts Datamonitor forecast that the merger …
Merck unveils $41 billion takeover of Schering-Plough
March 9, 2009Sales and Marketing MA, Merck
Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …
Schering-Plough invests in Scotland drug discovery centre
February 6, 2009Research and Development Merck, Scotland
Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …
Merck to streamline management structure
October 24, 2008Sales and Marketing Merck
Merck has announced a new round of job cuts and restructuring in a bid to update its business model and …
Experts play down Inergy cancer risk
September 5, 2008Sales and Marketing Merck, cv
Heart specialists have told patients to continue taking Schering-Plough and Merck's cholesterol-lowering drug Inergy, despite a study indicating that it …
